Letters
Drug combinations and all cause mortality in heart disease: No new insights were gained
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7509.159 (Published 14 July 2005) Cite this as: BMJ 2005;331:159
- Staffan Bjorck, medical adviser (staffan.bjorck@vgregion.se)
- Department of Healthcare Evaluation, Regionens Hus, SE 54180 Skövde, Sweden
EDITOR—Hippisley-Cox and Coupland conclude that the addition of angiotensin converting enzyme (ACE) inhibitors to combinations of drugs conferred no additional benefit in their study of patients in primary care with ischaemic heart disease.1 However, such a conclusion should be reached with caution.
The drugs were given to the patients with …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.